Literature DB >> 2575456

Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animal and human tissues.

P Galand1, C Degraef.   

Abstract

Paraffin sections from animal or human tissues fixed in different fixatives were submitted to immunostaining with the mouse monoclonal antibody 19A2, developed by Ogata et al. (1987a) against cyclin/PCNA. Detection of the bound antibody was performed by the indirect method with biotinylated sheep antibody and streptavidin-biotin-peroxidase complexes. No, or faint, nuclear staining was seen in material fixed in ethanol, Bouin, Bouin-Hollande, Carnoy or formaldehyde, whereas readily detectable immunocytochemical reaction was constantly observed over nuclei of methanol-fixed tissues. Hydrolysis with 2 N HCl prior to immunocytochemistry (as currently performed to render incorporated BrdU accessible to antibodies) somewhat improved the results with Bouin or Carnoy and markedly augmented the intensity of the peroxidase reactions in formaldehyde and in methanol-fixed tissues. The distribution of the positive nuclei in the two latter cases coincided with the proliferative compartment. On the other hand, double labelling with [3H]-thymidine and with the cyclin/PCNA antibody revealed that in methanol-fixed tissues the cyclin/PCNA labelling index did not differ by more than 6% from the [3H]-thymidine index. Besides the two labels overlapped in a proportion of labelled cells that was in reasonable agreement with expectation considering cells flow in and out of S phase since the time of [3H]-thymidine injection. This indicates that both labels recognize the same cells in this material. In contrast, in formaldehyde-fixed tissues, the cyclin/PCNA labelling index markedly exceeded the [3H]-thymidine labelling index. From this it is concluded that cyclin/PCNA immunostaining can be used: (1) In formaldehyde-fixed tissues (including existing material stored as paraffin blocks): for defining and mapping the proliferative (or germinative) compartment. (2) In methanol-fixed tissues as a substitute to the [3H]-thymidine autoradiographic labelling index. From this, a method is proposed (derived from classical 'double-labelling' technique) for measuring S phase duration in tissues fixed at a known interval time after a single labelling with [3H]-thymidine (or BrdU) and submitted to cyclin/PCNA immunocytochemical detection and to autoradiography (or to BrdU immunostaining).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2575456     DOI: 10.1111/j.1365-2184.1989.tb00223.x

Source DB:  PubMed          Journal:  Cell Tissue Kinet        ISSN: 0008-8730


  59 in total

1.  PCNA-positive cell distribution in depressed types of early carcinoma and adenoma of the large intestine.

Authors:  M Kobayashi; H Watanabe; Y Ajioka; S Maeo
Journal:  Gastroenterol Jpn       Date:  1992-10

2.  Role of macrophages in regeneration of liver.

Authors:  Y Shiratori; S Hongo; Y Hikiba; K Ohmura; T Nagura; K Okano; K Kamii; T Tanaka; Y Komatsu; T Ochiai; H Tsubouchi; M Omata
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

3.  Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.

Authors:  S M Siitonen; O P Kallioniemi; J J Isola
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

4.  PC10 monoclonal antibody to proliferating cell nuclear antigen as probe for cycling cell detection in developing tissues. A combined immunocytochemical and flow cytometric study.

Authors:  A Casasco; M Giordano; M Danova; M Casasco; A Icaro Cornaglia; A Calligaro
Journal:  Histochemistry       Date:  1993-03

5.  Proliferative potential of meningiomas evaluated by proliferating cell nuclear antigen expression.

Authors:  H Nakabayashi; M Sakaguchi; J Katsuyama; A Hakuba
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

6.  Expression of proliferating cell nuclear antigen in hyperplastic polyps, adenomas and inflammatory cloacogenic polyps of the large intestine.

Authors:  N J Carr; J M Monihan; U C Nzeako; L A Murakata; L H Sobin
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

7.  Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasms.

Authors:  E Karamitopoulou; E Perentes; M Melachrinou; T Maraziotis
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

8.  Proliferation indices as molecular pharmacodynamic endpoints in evaluation of anticancer drug effect in human solid tumors.

Authors:  J R Weaver; Y Gan; J L Au
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

9.  Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma.

Authors:  M Thomas; M Noguchi; H Kitagawa; K Kinoshita; I Miyazaki
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

10.  Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded sections.

Authors:  A Sasaki; H Naganuma; R Kimura; S Isoe; S Nakano; H Nukui; K Suzuki; A Kawaoi
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.